Skip to main content
. 2022 Jun 30;11(6):2565–2572. doi: 10.4103/jfmpc.jfmpc_1126_21

Table 2.

Correlation between age, nodule size, nodularity and TSH with VEGF expression

VEGF P

1+ & +2 (Negative/Equivocal) (n=35) +3 (Positive) (n=26)
Age group (years)
 30-40 11 (31.4%) 8 (30.8%) 0.992
 41-50 19 (54.3%) 14 (53.8%)
 >50 5 (14.3%) 4 (15.4%)
Size of nodule (cm)
 <5 18 (51.4%) 12 (46.2%) 0.683
 >5 17 (48.6%) 14 (53.8%)
Nodularity
 STN 14 (40.0%) 16 (61.5%) 0.096
 Multi-nodular 21 (60.0%) 10 (38.5%)
TSH (Benign n=37)
 <1.39 11 (40.7%) 2 (20.0%) <0.001
 1.4-2.49 14 (51.9%) 1 (10.0%)
 >2.5 2 (7.4%) 7 (70.0%)
TSH (Malignant n=24)
 <1.39 4 (50.0%) 1 (6.2%) 0.004
 1.4-2.49 4 (50.0%) 5 (31.2%)
 >2.5 0 (0.0%) 10 (62.5%)
TSH (Total n=61)
 <1.39 15 (42.9%) 3 (11.5%) <0.001
 1.4-2.49 18 (51.4%) 6 (23.1%)
 >2.5 2 (5.7%) 17 (65.4%)